Human rhinovirus (HRV) is a frequent respiratory pathogen, responsible for a large proportion of cases of the ''common cold'' and linked to acute asthma, especially in children. T cell responses to HRV and their contribution to HRV-associated pathology were investigated. T cells were obtained from tonsils removed from children at routine tonsillectomy. Proliferative and cytokine responses were measured after in vitro restimulation with purified HRV preparations of both major and minor serotypes. Most tonsils tested showed T cell proliferation, and responses to multiple serotypes in one tonsil were observed frequently. Responding T cells were CD4-positive and produced interleukin-2 and interferon-g but no interleukin-4. Thus, children respond to HRV, a proportion of the response is serotype -cross-reactive, and a Th1 reaction predominates. In addition to contributing to protection, this response may enhance expression of virus receptor and be implicated in the immunopathology of HRV infection.
Human rhinovirus (HRV) is the most common cause of
Previous studies have characterized the murine T cell response to HRV [6] . HRV stimulated T cell proliferation and upper respiratory tract disease in humans. Although HRV seldom leads to serious illness, infection is associated with considinterleukin (IL)-2 production. In contrast to antibody, the T cell response was directed largely at internal capsid epitopes erable loss of working time in developed countries and with other acute respiratory illness, especially exacerbations of allercommon to many serotypes. This suggested that HRV may be able to stimulate cross-reactive Th1-type responses, with gic asthma, in both children and adults. Therefore, there is a need for better understanding of the immunopathology of HRV implications in the natural history of the viral infection as well as in the pathogenesis of the other forms of respiratory disease. infection and of the molecular processes that link this immunopathology with other forms of pulmonary disease [1 -3] .
The conclusions of the murine studies were, however, limited; HRV does not produce productive infection in rodents [7] . Like other picornaviruses, HRV induces serotype-specific neutralizing antibodies in both humans and experimental aniIn this study, the human T cell proliferative and cytokine responses to a variety of serotypes have been analyzed by use mals, usually recognizing only 1 of ú100 known serotypes. The specificity and slowness of response, detectable in nasal of human tonsil, a local nasopharyngeal mucosal lymphoid tissue where HRV infection first manifests. The cytokine specsecretions 2 -3 weeks after infection when virus is cleared from the upper respiratory tract [4, 5] , has made it difficult to devise trum demonstrated may be important not only in the immunopathology of HRV infection but also in the respiratory complia strategy to stimulate cross-reactive antibodies of protective value in the general population. The implication of this delay cations with which it has been associated. is that antibody probably plays little role in the early stages of HRV infection. Local cytokine production (e.g., interferon
Materials and Methods [IFN] ) is likely to play the more dominant role during this period, although reactivation of a memory T cell response could Preparation of HRV. Methods for viral growth and purification also be a component.
have been described previously [6] . Virus was purified from HeLaderived epithelial cell lysates, fractionated through a 15%-45% continuous sucrose gradient, and then detected by ELISA with HRV serotype-specific rabbit antisera. HRV-15 (major serotype) [8] were used unless otherwise indicated. 15) and minor (HRV-1A or HRV-2) forms of the virus. Of 34 was forced through sterile 125-mm-pore nylon mesh. Cells were tonsils tested, 27 (75%) responded (SI ú2) to at least 1 serowashed, resuspended in 101 HBSS-isotonic Percoll, and fractiontype, with no significant difference between major and minor ated by flotation through a discontinous Percoll gradient (800 g, serotypes (average SI Å 4.2 { 2.9 and 3.9 { 2.2), although 7 30 min). Low-density cells (those found at the interface between of 8 responses with SIs ú9 were to the major serotype. Correla-30% and 40% and between 40% and 50% Percoll) and high-density tion between responses to major and minor serotypes (figure cells (50%-60% and 60%-70% interface) were collected, washed, 1B) shows that in general, nonresponders responded to neither and cultured overnight (5 1 10 6 /mL in RPMI with 10% FCS, 10 serotype (7/34), although ConA responses were normal. OvermM HEPES, 2 mM L-glutamine, 50 mM 2-mercaptoethanol, 100 all, responses to major and minor serotypes correlated (r Å U/mL penicillin, 100 mg/mL streptomycin, and 2.5 mg/mL ampho-.569, P õ .001), although individual tonsils showing a stronger tericin B [complete medium]). Media and supplements were from Life Technologies (Paisley, UK).
response to one virus than to another were observed.
Enriched resting T cells were from high-density 24-h nonadher- was not required.
Cytokine assays. Supernatants were collected and stored at
The cytokine profile of responding T cells stimulated with 020ЊC. IL-4 and IFN-g were tested by ELISA (Genzyme, Cam-HRV-15 or HRV-1A is summarized in figure 2A . HRV prolifbridge, MA). IL-2 was tested by use of a CTLL bioassay; ELISA eration always correlated with IL-2 and IFN-g release, but no confirmed that under these conditions, the bioassay correlated with IL-4 (i.e., õ10 pg/mL) was detected, in either proliferating or supernatant IL-2, not with other cytokines. nonproliferating cultures. Figure 2B documents this further: IL-2 concentrations were maximal after 24 h, then declined rapidly; IFN-g levels peaked at day 3 and remained high Results throughout the culture period. Initial experiments demonstrated an HRV-specific, dose-dependent response in T cells isolated from tonsil (data not Discussion shown). The optimal dose in preliminary experiments, 4 mg/ mL, was used routinely. No response was detected when Although HRV is a common pathogen in humans, few studies have addressed cell-mediated responses to HRV. Therefore, ''mock'' HRV from HeLa cultures lysed and purified in the same way was used (data not shown).
T cell responses to HRV (both major and minor serotypes) were examined, by use of cells from tonsil, and show clearly Figure 1A summarizes SIs when T cells plus APC from a series of 34 unselected tonsils were cultured with major (HRVthat such responses can be demonstrated.
/ 9d31$$se29 07-24-97 11:56:02 jinfa UC: J Infect . Results using HRV-1A and -2 were combined since these 2 serotypes are structurally very similar [7] , and responses showed no significant difference between them. B, Stimulation index of response to HRV-15 in 34 tonsils plotted vs. stimulation index to HRV-1A. Similar results were obtained for HRV-2. Line shows regression analysis (r Å .569; P õ .001). C, Representative example of response of tonsillar T cells from 1 patient to panel of HRV serotypes (stimulation indices). Similar results were obtained for 6 of 8 patients tested. HRV-1A, -2, and -29 are minor serotypes, while HRV-3, -7, -14, and -15 belong to major serotype group.
One potential disadvantage of using tonsillar T cells is that same may apply in the tonsil. Nevertheless, the frequency of the response observed here was surprising, suggesting that most surgery is performed after repeated upper respiratory tract infections, raising the possibility that these tonsils are not reprepersons have responded to HRV exposure in vivo by priming a T cell antigen-specific response. sentative. Serotype-specific proliferative responses to rhinovirus have been found in peripheral blood mononuclear cells
The results do not exclude HRV stimulation of primary T cell responses in vitro, or HRV acting as a superantigen, and these after, but not before, priming in vivo by infection [9] , and the / 9d31$$se29 07-24-97 11:56:02 jinfa UC: J Infect possibilities are being explored, but preliminary work in our labobut the balance of the cytokine profile is clearly tilted toward Th1. This is consistent with previous HRV work using periphratory suggests that they are unlikely. The study, however, does clarify that in humans, as in mice, HRV is immunogenic with eral blood T cells (rather than tonsil) and looking at experimental infection rather than natural history [10] . respect to T cells and that immunogenicity in vitro does not depend on infectivity, since inactivated virus induced similar reProduction of Th1 cytokines in response to HRV has implications for understanding the relationship between HRV infecsponses. Furthermore, a proportion of these T cells may be directed at serotype-cross-reactive epitopes, since responses were tion and host immune responses. Antigen-specific anti-HRV secretory IgA can be both neutralizing and protective against either to the panel of 7 serotypes or to no virus. Future studies looking at clonal analysis will therefore be of interest.
future challenge with cross-reactive virus [5] . Th1 cytokines (such as IFN-g) may antagonize this by inhibiting the humoral Although the presence of a CD8 T cell response to HRV is not excluded here, and such CD8 cells will undoubtedly play responses [11] and delaying induction of neutralizing antibody [12] . On the other hand, IFN-g may also contribute to virus a role in the elimination of infected cells, the data reported here relate primarily to CD4 cells. Responses to HRV were clearance by increasing cellular cytotoxic responses. Release of Th1 cytokines may not only modulate host capacpredominantly Th1 CD4 type, abolished by CD4 but not CD8 depletion and by removal of HLA-DR -expressing APC. Furity to mount effective responses to HRV but also participate in the immunopathology of HRV infection and, in particular, thermore, unexpectedly for a mucosal infection, supernatants from HRV-stimulated T cells contain IL-2 and IFN-g but no in linking HRV infection and acute asthma [2, 3] . In this context, IFN-g and other Th1 cytokines can up-regulate expression detectable IL-4. Trace undetectable IL-4 might be produced,
